The Changing Asthma Management Landscape and Need for Appropriate SABA Prescription Christian DomingoDave Singh Commentary Open access 30 January 2023 Pages: 1301 - 1316
TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis Tomas GanzElizabeta NemethTerrance D. Barrett Review Open access 23 January 2023 Pages: 1317 - 1333
What Do We Need to Know About Rising Rates of Idiopathic Pulmonary Fibrosis? A Narrative Review and Update Joseph V. Pergolizzi Jr.Jo Ann LeQuangGiustino Varrassi Review 24 January 2023 Pages: 1334 - 1346
Τhe Endless Beauty of Metformin: Does It Also Protect from Skin Aging? A Narrative Review Evanthia GouveriNikolaos Papanas Review 30 January 2023 Pages: 1347 - 1356
Aminoglycoside-Related Nephrotoxicity and Ototoxicity in Clinical Practice: A Review of Pathophysiological Mechanism and Treatment Options Tyler A. LeTasneem HibaAlan D. Kaye Review 04 February 2023 Pages: 1357 - 1365
Tetracycline-, Doxycycline-, Minocycline-Induced Pseudotumor Cerebri and Esophageal Perforation Alexis L. AngeletteLauren L. RandoAlan D. Kaye Review 10 February 2023 Pages: 1366 - 1378
Histology-Agnostic Drugs: A Paradigm Shift—A Narrative Review André MansinhoRicardo Miguel FernandesAntónio Vaz Carneiro Review Open access 23 November 2022 Pages: 1379 - 1392
Breast Cancer Screening Should Embrace Precision Medicine: Evidence by Reviewing Economic Evaluations in China Jingjing JiangShan JiangYuanyuan Gu Review Open access 17 February 2023 Pages: 1393 - 1417
GLP-1 RAs in Spain: A Short Narrative Review of Their Use in Real Clinical Practice Irene RomeraMiriam Rubio-de SantosIgnacio Conget Review Open access 23 February 2023 Pages: 1418 - 1429
The Impact of Obesity in Saudi Arabia: Healthcare Resource Use and Costs Associated with Obesity-Related Complications Hussain A. Al-OmarAli AlshehriSaleh A. Alqahtani Original Research Open access 21 January 2023 Pages: 1430 - 1443
Comparison of Outcomes of Phacoemulsification Combined with Endoscopic Cyclophotocoagulation, iStent, or Both in the Management of Open-Angle Glaucoma Galia A. DeitzJennifer L. PatnaikMina B. Pantcheva Original Research 24 January 2023 Pages: 1444 - 1455
Bioinformatics Identification of Therapeutic Gene Targets for Gastric Cancer Yuanting LiMinghao ChenBin Han Original Research 24 January 2023 Pages: 1456 - 1473
Real-World Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Interim Report of a Post-Marketing Surveillance in Japan Takashi OguraYoshikazu InoueToshihiro Nukiwa Original Research Open access 24 January 2023 Pages: 1474 - 1493
Human Albumin Infusion for the Management of Liver Cirrhosis and Its Complications: An Overview of Major Findings from Meta-analyses Xiaojie ZhengZhaohui BaiXingshun Qi Original Research 25 January 2023 Pages: 1494 - 1529
Self-Administration of Burosumab in Children and Adults with X-Linked Hypophosphataemia in Two Open-Label, Single-Arm Clinical Studies Takuo KubotaNoriyuki NambaKeiichi Ozono Original Research Open access 31 January 2023 Pages: 1530 - 1545
Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies Jonathan BarrattFrank DellannaMichael Reusch Original Research Open access 07 February 2023 Pages: 1546 - 1559
Remote-Access Thyroidectomy in the Pediatric Population: a Systematic Review Oded CohenAntti A. MäkitieAlfio Ferlito Original Research 07 February 2023 Pages: 1560 - 1570
Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison Raymond WongJesse FishmanMei Sheng Duh Original Research Open access 07 February 2023 Pages: 1571 - 1589
Genetic Evidence Supporting Causal Roles of mTOR-Dependent Proteins in Rheumatic Fever: A Two-Sample Randomized Mendelian Study Yan-Fei MuQian WangCai-Hong Wang Original Research 11 February 2023 Pages: 1590 - 1600
High Clinical Burden of Influenza Disease in Adults Aged ≥ 65 Years: Can We Do Better? A Systematic Literature Review Jakob LangerVerna L. WelchIsabelle J. Whittle Original Research Open access 15 February 2023 Pages: 1601 - 1627
Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Study Yi LiKaoru ToyamaXiaojie Wu Original Research Open access 15 February 2023 Pages: 1628 - 1643
Levothyroxine Bioequivalence Study and Its Narrow Therapeutic Index: Comparative Bioavailability Results Between Two Formulations Available in Latin America Carlos Walter BertonciniMaria Juliana Cruz PalaciosIsaac Arbeláez Original Research Open access 24 November 2022 Pages: 1644 - 1654
Economic Impact of Transformation to Acute Myeloid Leukemia Among Actively Managed Patients with Higher-Risk Myelodysplastic Syndromes in the United States Vamsi KotaAugustina OgbonnayaMehul Dalal Original Research Open access 24 November 2022 Pages: 1655 - 1669
Patient and Healthcare Professional Insights of Home- and Remote-Based Clinical Assessment: A Qualitative Study from Spain and Brazil to Determine Implications for Clinical Trials and Current Practice Simón LalanzaCatalina PeñaAndreia Lemos Gil Original Research Open access 16 February 2023 Pages: 1670 - 1685
Evaluating the Benefits of TACE Combined with Lenvatinib Plus PD-1 Inhibitor for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus Xinhua ZouQingyu XuGuowen Yin Original Research 20 February 2023 Pages: 1686 - 1704
Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences Alexander T. CohenJanvi SahXuemei Luo Original Research Open access 22 February 2023 Pages: 1705 - 1735
Association Between Multidrug-Resistant Bacteria and Mortality in Critically Ill Patients Gary DuclosInes LakbarMarc Leone Original Research 22 February 2023 Pages: 1736 - 1749
Venous Thromboembolism Recurrence Among Patients Who Abandon Oral Anticoagulant Therapy in the USA: A Retrospective Longitudinal Study Mark AlbertsMaryia ZhdanavaAkshay Kharat Original Research Open access 24 February 2023 Pages: 1750 - 1764
Adherence to Triple Single-Pill Combination of Perindopril/Indapamide/Amlodipine: Findings from Real-World Analysis in Italy Claudio BorghiPathiyil Balagopalan JayagopalJacques R. Snyman Original Research Open access 24 February 2023 Pages: 1765 - 1772
Development and Preliminary Validation of an Instrument to Measure Symptoms and Impacts in Patients with Proliferative Diabetic Retinopathy Diana RofailSteven ShermanDiana V. Do Original Research Open access 27 February 2023 Pages: 1773 - 1786
Apremilast Use in Severe Psoriasis: Real-World Data from Central and Eastern Europe Petra CetkovskáIva DediolKhalid Mamun Original Research Open access 02 March 2023 Pages: 1787 - 1802
Cost Analysis of Aprotinin Reintroduction in French Cardiac Surgery Centres: A Real-World Data-Based Analysis Pascal ColsonJean-Luc Fellahifrom the ARCOTHOVA Group Original Research Open access 03 March 2023 Pages: 1803 - 1817
Association Between Myasthenia Gravis–Activities of Daily Living (MG-ADL) and EQ-5D-5L Utility Values: The Additional Effect of Efgartigimod on Utilities Sarah DewildeCynthia Z. QiMathieu F. Janssen Original Research Open access 03 March 2023 Pages: 1818 - 1829
Patient Blood Management in Transurethral Resection Surgery: Overview and Strategy Analysis from a French Tertiary Hospital Bruno PasteneRaphaël BernardMarc Leone Original Research 03 March 2023 Pages: 1830 - 1837
Cemiplimab as Second-Line Therapy for Patients with Recurrent Cervical Cancer: A United States-based Cost-effectiveness Analysis Kun LiuYouwen ZhuHong Zhu Original Research 04 March 2023 Pages: 1838 - 1849
Real-World Racial Variation in Treatment and Outcomes Among Patients with Peripheral Artery Disease Keith C. FerdinandKay SadikDavid G. Armstrong Original Research Open access 06 March 2023 Pages: 1850 - 1866
Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications Peter C. TaylorThomas BieberAndreas Wollenberg Brief Report Open access 20 February 2023 Pages: 1867 - 1883
Safety and Effectiveness Analyses of Dolutegravir/Lamivudine in Patients with HIV: 2-Year Report of Post-Marketing Surveillance in Japan Ayano TofukujiHaruyuki HongoTomoyuki Watanabe Brief Report Open access 25 February 2023 Pages: 1884 - 1898
Clinical Characteristics, Treatment Patterns, and Effectiveness in Chinese Patients with Angina Pectoris Using Electronic Patient-Reported Outcomes: Protocol for a Multicenter, Prospective, Cohort Study (GREAT) Xiliang ZhaoZichuan TongYong Zeng Study Protocol 04 February 2023 Pages: 1899 - 1912
